Structure |
Chemical Name |
CAS |
MF |
![Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-](/CAS/20210305/GIF/1431216-61-3.gif) |
Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)- |
1431216-61-3 |
C30H32F6N4O3 |
 |
Tafluprost Impurity 15 |
|
|
 |
Rosuvastatin Impurity 159 (Sodium salt) |
|
|
 |
Rosuvastatin Impurity 140 |
|
|
 |
Rosuvastatin Impurity 130 |
|
|
 |
Terlipressin Impurity 1 (des-Gly1) |
|
|
 |
Brivaracetam Impurity 66 |
|
|
 |
2-Acetoxymethyl1-3-Methyl-4- |
112525-75-4 |
C11H12F3NO3 |
 |
Ertapenem Impurity D(USP) |
|
|
 |
3-(N-Benzyl-N-methylamino)propiophenone hydrochloride |
5409-62-1 |
C17H20ClNO |
![2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-4-hydroxy-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S,4S)-](/CAS/20210305/GIF/869884-24-2.gif) |
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-4-hydroxy-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (1S,4S)- |
869884-24-2 |
C23H26N2O3 |
 |
Azilsartan Medoxomil Potassium impurity209 |
|
|
 |
Nelarabine impurity 01 |
|
|
 |
Cyclopropanamine, 2-(3-fluorophenyl)-, (1R,2S)- (9CI) |
220353-83-3 |
C9H10FN |
![1(2H)-Naphthalenone, 4-hydroxy-3-methyl-2-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ylidene]-](/CAS/20210305/GIF/693781-59-8.gif) |
1(2H)-Naphthalenone, 4-hydroxy-3-methyl-2-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ylidene]- |
693781-59-8 |
C31H40O2 |
 |
Bisoprolol Impurity 50 |
|
|
 |
Milnacipran Impurity 26 |
|
|
 |
Olodaterol Impurity 15 |
|
|
![2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylthio)phenyl]-, hydrochloride (1:1)](/CAS/20211123/GIF/1447814-82-5.gif) |
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylthio)phenyl]-, hydrochloride (1:1) |
1447814-82-5 |
C18H16Cl2N2S |
 |
Pitavastatin Impurity 104 |
|
|
 |
Tegoprazan Impurity 8 |
|
|
 |
Atomoxetine EP Impurity G DiHCl (Mixture of Diastereomers) |
2706536-33-4 |
C27H34N2O2 |
 |
Nirmatrelvir Impurity 10 |
|
|
 |
Levosimendan Nitrosogenin Impurities |
|
|
 |
7-ブロモアセチルアミノセファロスポラン酸 |
26973-80-8 |
C12H13BrN2O6S |
 |
Bumetanide Impurity 20 |
|
|
 |
Rocuronium Bromide Impurity 28 、29 |
|
|
 |
Roxadustat Impurity 22 |
|
|
 |
Olaparib Impurity 41 |
|
|
 |
Perospirone Impurity 22 |
|
|
 |
Perospirone Impurity 14 |
87691-94-9 |
C15H20BrN3S |
 |
Dolutegravir Impurity 22 |
|
|
 |
Tenofovir Disoproxil Fumarate impurity N |
1962114-92-6 |
C29H44N10O14P2 |
 |
Prednisolone Impurity 7 |
61549-70-0 |
C21H26O6 |
 |
Tenofovir Related Compound 10 |
16958-60-4 |
C8H11N5O |
 |
N-(4-methyl-3-(N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
|
C31H33N7O2 |
 |
N1-benzyl-N1,4-dimethyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C24H23N5 |
 |
(E)-4-(((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3- yl)methyl)(methyl)amino)-4-oxobut-2-enoic acid |
|
C21H18FN3O5S |
 |
TROXACITABINE |
145511-98-4 |
C8H11N3O4 |
 |
XXZJUZXKBFUPQH-IKGGRYGDSA-N |
1618657-31-0 |
C18H17FO4 |
 |
6-methyl-2-oxo-5-pyridin-2-yl-1H-pyridine-3-carbonitrile |
106637-42-7 |
C12H9N3O |
 |
Levofloxacin Impurity 15 |
94714-58-6 |
C14H12F4O4 |
 |
Losartan Impurity 2 |
1407521-00-9 |
C22H20ClN3O |
 |
Epoxy Exemestane (6-Alfa Isomer) |
152764-24-4 |
C20H24O3 |
![6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine](/CAS/20180601/GIF/1187966-94-4.gif) |
6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine |
1187966-94-4 |
C20H16FN |
 |
2-methoxy-1,7,9-trimethylpurine-6,8-dione |
51168-26-4 |
C9H12N4O3 |
 |
2-クロロ-N-(2,5-ジメチルフェニル)アセトアミド |
5177-35-5 |
C10H12ClNO |
 |
(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate |
319924-73-7 |
C10H17ClO4 |
 |
(R)-2-(2-aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide |
1684452-80-9 |
C21H24N4O2S |
![1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[(3,3-ジフェニルプロピル)メチルアミノ]-1,1-ジメチルエチル]5-エチル](/CAS/20180703/GIF/210579-71-8.gif) |
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[(3,3-ジフェニルプロピル)メチルアミノ]-1,1-ジメチルエチル]5-エチル |
210579-71-8 |
C37H44ClN3O6 |
 |
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
2169267-53-0 |
C11H7ClFNO |
 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-99-9 |
C37H42F2N8O4 |
 |
5-(2-fluorophenyl)-N-methyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carboxamide |
2054536-04-6 |
C17H14FN3O3S |
 |
Ozagrel Impurity 10 |
|
|
 |
Paxlovid Impurity 20 |
|
|
 |
Related impurities 7 of fluoxetine sodium |
|
|
 |
Revefenacin Impurity 16 |
|
|
 |
(E)-Olopatadine |
113806-06-7 |
C21H23NO3 |
 |
ネマジピンB |
79925-38-5 |
C19H21Cl2NO4 |
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole](/CAS/GIF/957470-59-6.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole |
957470-59-6 |
C24H24F2N4O6S |
 |
4-Epi-6-epi Doxycycline |
97583-08-9 |
C22H24N2O8 |
 |
Ethyl 3,4-O-Isopropylidene-5-O-methanesulfonylshikimate |
204254-84-2 |
C13H20O7S |
![2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris-](/CAS/20180808/GIF/390800-88-1.gif) |
2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- |
390800-88-1 |
C57H69B3N12O9 |
![Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)](/CAS/GIF/108928-81-0.gif) |
Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) |
108928-81-0 |
C25H37NO4 |
![3-[3-(ピペリジノメチル)フェノキシ]-1-プロパンアミン](/CAS/GIF/73278-98-5.gif) |
3-[3-(ピペリジノメチル)フェノキシ]-1-プロパンアミン |
73278-98-5 |
C15H24N2O |
 |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III |
95603-44-4 |
C35H38Cl6O14 |
 |
4-(3-AMino-phenyl)-Morpholin-3-one |
1082495-22-4 |
C10H12N2O2 |
 |
piperacillinylaMpicillin |
|
|
 |
Celecoxib iMpurity-B |
|
|
 |
EMtricitabine iMpurity B |
|
|
![(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone](/CAS/GIF/14842-41-2.gif) |
(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone |
14842-41-2 |
C10H10N2O4 |
 |
BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride |
132004-28-5 |
C14H21BrN2 |
 |
2-(DiMethylcarbaMoyl)benzoic acid, 97% |
20320-37-0 |
C10H11NO3 |
 |
RAC DESMETHYL CITALOPRAM HYDROCHLORIDE |
97743-99-2 |
C19H19FN2O |
 |
2-Demethoxy-4-methoxy urapidil |
34661-79-5 |
C20H29N5O3 |
 |
1-(5-O-アセチル-β-D-リボフラノシル)-1H-1,2,4-トリアゾール-3-カルボアミド |
58151-87-4 |
C10H14N4O6 |
![4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid](/CAS/GIF/1228551-91-4.gif) |
4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid |
1228551-91-4 |
C32H41Cl3N6O4 |
![3-(6,7-Dihydro-2-Methyl-7-oxo-3-propyl-2H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride](/CAS/GIF/501120-42-9.gif) |
3-(6,7-Dihydro-2-Methyl-7-oxo-3-propyl-2H-pyrazolo[4,3-d]pyriMidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride |
501120-42-9 |
C17H19ClN4O4S |
![(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride](/CAS/GIF/1217655-87-2.gif) |
(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4'-fluoro[1,1'-biphenyl]-4-yl)-piperidine Hydrochloride |
1217655-87-2 |
C25H25ClFNO3 |
![Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione)](/CAS/20180808/GIF/216453-74-6.gif) |
Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) |
216453-74-6 |
C25H32O6 |
 |
6(S)-Hydroperoxy Simvastatin |
149949-01-9 |
C25H38O7 |
 |
6,7-ジメチル-8-リビチルルマジン |
2535-20-8 |
C13H18N4O6 |
![2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one](/CAS/GIF/197010-20-1.gif) |
2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one |
197010-20-1 |
C24H29NO4 |
 |
5,6-TRANS-ビタミンD2 |
51744-66-2 |
C28H44O |
 |
2-isonicotinoyl-5,6-diMethoxy-2,3-dihydro-1H-inden-1-one |
923571-15-7 |
C17H15NO4 |
 |
4-(2-nitrophenyl)Morpholin-3-one |
845729-41-1 |
C10H10N2O4 |
 |
Irbesartan IMpurity E |
|
C25H28N6O |
 |
LeflunoMide EP IMpurity G |
724429-16-7 |
C12H12N2O2 |
 |
Telmisartan impurity C |
|
|
 |
Itraconazole iMpurity E |
|
|
![N-(5-クロロ-2-ピリジル)-N'-[(1R,2R,4R)-4-(ジメチルカルバモイル)-2-[(5-メチル-6,7-ジヒドロ-4H-チアゾロ[5,4-C]ピリジン-2-カルボニル)アミノ]シクロヘキシル]オキサミド](/CAS/20150408/GIF/1255529-24-8.gif) |
N-(5-クロロ-2-ピリジル)-N'-[(1R,2R,4R)-4-(ジメチルカルバモイル)-2-[(5-メチル-6,7-ジヒドロ-4H-チアゾロ[5,4-C]ピリジン-2-カルボニル)アミノ]シクロヘキシル]オキサミド |
1255529-24-8 |
C24H30ClN7O4S |
 |
1,4,7,10-テトラアザシクロドデカン-1,7-二酢酸 |
112193-75-6 |
C12H24N4O4 |
![7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one](/CAS/GIF/53944-31-3.gif) |
7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one |
53944-31-3 |
C14H11NO2 |
 |
4-アミノ-2-メチル-10H-チエノ(2,3-B)(1,5)-ベンゾジアゼピン |
612503-08-9 |
C12H11N3S |
![IMp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one](/) |
IMp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one |
|
|
![IMp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H- dibenzo[b,e][1,4]diazepine](/) |
IMp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H- dibenzo[b,e][1,4]diazepine |
|
|
 |
tris((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)amine |
|
C33H27F3N4 |
 |
Esmolol impurity C |
|
|
 |
(R)-(+)-(3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE |
117604-42-9 |
C6H15Cl2NO |
 |
17-ヒドロキシ-21-(アセチルオキシ)プレグナ-4-エン-3,20-ジオン |
640-87-9 |
C23H32O5 |